Abstract
Immunopathologic events mediating tissue injury have been divided by the scheme of Coombs and Gell (1968) into four types: type I or anaphylactic (immediate) hypersensitivity; type II or cytotoxic; type III or immune complex-mediated; type IV or cell-mediated (delayed) hypersensitivity. Such a scheme, while useful didactically, is an oversimplification because of the complex interrelationships which actually exist between the cells and mediators involved in each ‘type’ of response. Thus: (1) mediator release can be triggered from mast cells by C3a and C5a (complement components usually associated with immune complex disease) (Lepow et al., 1970; Vallota and Müller-Eberhart , 1973), and possibly by vasoactive peptides like bradykinin (Spragg, 1974). On the other hand, the basophils release a kallikrein which can generate bradykinin from serum kininogen (Newball et al., 1975). (2) Basophils respond to lymphocyte-derived chemotactic stimuli (presumably components of so-called type IV reactions) (Ward et al., 1975; Boetcher and Leonard, 1973). (3) Vasoactive amines (released during immediate hypersensitivity reactions) are important both for permitting deposition of immune complexes (Kniker and Cochrane, 1965), and apparently in eliciting delayed hypersensitivity reactions (Gershon et al., 1975).
Supported by Grants Nos. AI 07290 and AI 12810 from The National Institutes of Health. From the Johns Hopkins University School of Medicine at the Good Samaritan Hospital, publication No. 299 of the O’Neill Research Laboratories, The Good Samaritan Hospital.
In the 24 months following the completion of this chapter in early 1976, several important developments occured. Among them are those included in the footnotes (except 7 and 12) to this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, G.K., III, Lichtenstein, L.M.: Antagonism of antigen-induced contraction of guinea pig and human airways. Nature 270, 255–257 (1977)
Adams, G.K., III: Unpublished observations (1976)
Ash, A.S.F., Schild, H.O.: Receptors mediating some actions of histamine. Brit. J. Pharmacol. 27, 427–439 (1966)
Askenase, P.W.: Cutaneous basophil hypersensitivity in contact-sensitized guinea pigs. I. Transfer with immune serum. J. exp. Med. 138, 1144–1155 (1973)
Askenase, P.W.: Role of basophils, mast cells, and vasoamines in hypersensitivity reactions with a delayed time course. In: Kallos, P., Waksman, B.H., deWeck, A.L. (Eds.): Progress in Allergy, Vol.XXIII, pp. 199–320. Basel: Karger 1977
Augstein, J., Farmer, J.B., Lee, T.B., Sheard, P., Tattersall, M.L.: Selective inhibition of slow reacting substance of anaphylaxis. Nature (New Biol.) 245, 215–217 (1973)
Austen, K.F.: Histamine and other mediators of allergic reactions. In: Samter, M. (Ed.): Immunologic Diseases, 2nd Ed., Vol.1, pp.332–355. Boston: Little Brown 1971
Austen, K.F., Orange, R.P.: Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Amer. Rev. resp. Dis. 112, 423–435 (1975)
Avella, J., Madsen, J.E., Binder, H.J., Askenase, P.W.: Effect of histamine H2 receptor antagonists on delayed hypersensitivity. Lancet 1978I, 624–626
Bach, M.K., Brashler, J.R.: In vivo and in vitro production of a slow reacting substance in the rat upon treatment with calcium ionophores. J. Immunol. 113, 2040–2044 (1974)
Bamzai, A.K., Kretschmer, R.R., Gotoff, S.P.: Mononuclear cell-derived factor enhances antigen-induced leukocyte histamine release. Clinical Research 25, 614A (Abs.) (1977)
Baudry, M., Martres, M.-P., Schwartz, J.C.: H1 and H2-receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices. Nature (Lond.) 253, 362–363 (1975)
Baxter, J.H., Adamik, R.: Control of histamine release: effects of various conditions on rate of release and rate of cell desensitization. J. Immunol. 114, 1034–1041 (1975)
Beaven, M.A.: Histamine. New Engl. J. Med. 294, 30–36 and 320–325 (1976)
Becker, E.L., Henson, P.M.: In vitro studies of immunologically induced secretion of mediators from cells and related phenomena. Advanc. Immunol. 17, 93–193 (1973)
Benveniste, J.: Platelet activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature (Lond.) 249, 581–582 (1974)
Berridge, M.J.: The mode of action of 5-hydroxytryptamine. J. exp. Biol. 56, 311–321 (1972)
Black, J.W.: Histamine receptors. In: Klinge, E. (Ed.): Proc. 6th Int. Cong. Pharmacology, Finnish Pharmacological Society, Vol.1, pp. 3–16. Helsinki 1975
Black, J.W., Duncan, W.A.M., Durant, C.J., Ganellin, C.R., Parsons, E.M.: Definition and antagonism of histamine H2-receptors. Nature (Lond.) 236, 385–390 (1972)
Bloch, K.J.: Reaginic and other homocytotropic antibodies: diverse immunoglobulins with common function. In: Goodfriend, L., Sehon, A.H., Orange, R.P. (Eds.): Mechanisms in Allergy. Reagin-mediated Hypersensitivity, pp. 11–32. New York: Marcel Dekker 1973
Boetcher, D.A., Leonard, E. J.: Basophil Chemotaxis augmentation by a factor from stimulated lymphocyte cultures. Immunol. Commun. 2, 421–429 (1973)
Bourne, H.R., Lichtenstein, L.M., Henney, C.S., Melmon, K.L., Weinstein, Y., Shearer, G. M.: Modulation of inflammation and immunity by cyclic AMP. Science 184, 19–28 (1974)
Brimblecombe, R.W., Duncan, W.A.M., Durant, G.J., Ganellin, C.R., Parsons, E.M., Black, J.W.: The pharmacology of Cimetidine, a new histamine H2-receptor antagonist. Brit. J. Pharmacol. 53, 435P–436P (abs.) (1975)
Brocklehurst, W.E.: The release of histamine and formation of a slow reacting substance (SRS-A) during anaphylactic shock. J. Physiol. (Lond.) 151, 416–435 (1960)
Brocklehurst, W.E.: Slow reacting substance and related compounds. In: Waksman, B.H., Kallós, P. (Eds.): Progress in Allergy, Vol. VI, pp. 539–558. Basel: S. Karger 1962
Brocklehurst, W.E.: “SRS-A”: The slow reacting substance of anaphylaxis. Biochem. Pharmacol. 12, 431–435 (1963)
Bruce, C.A., Rosenthal, R. R., Lichtenstein, L.M., Norman, P.S.: Quantitative inhalation bronchial challenge in ragweed hay fever patients: a comparison with ragweed-allergic asthmatics. J. Allergy clin. Immunol. 56, 331–337 (1975)
Bryant, D.H., Burns, M.W., Lazarus, L.: Identification of IgG antibody as a carrier of reaginic activity in asthmatic patients. J. Allergy clin. Immunol. 56, 417–428 (1975)
Busse, W.W., Sosman, J.: Decreased H 2 histamine response of granulocytes of asthmatic patients. J. Clin. Invest. 59, 1080–1087 (1977)
Capurro, N., Levi, R.: The heart as a target organ in systemic allergic reactions. Comparison of cardiac anaphylaxis in vivo and in vitro. Circulat. Res. 36, 520–528 (1975)
Chakrin, L.W., Krell, R.D., Mengel, J., Young, D., Zaher, C., Wardell, J.R.: Effect of a histamine H2-receptor antagonist on immunologically induced mediator release in vitro. Agents Actions 4, 297–303 (1974)
Chand, N., Eyre, P.: Classification and biological distribution of histamine receptor sub-types. Agents Actions 5, 277–295 (1975)
Clark, R.A.F., Gallin, J.I., Kaplan, A.P.: The selective eosinophil chemotactic activity of histamine. J. exp. Med. 142, 1462–1476 (1975)
Clark, R.A.F., Sandler, J.A., Gallin, J.L., Kaplan, A.P.: Histamine modulation of eosinophil migratioN. J. Immunol. 118, 137–145 (1977)
Cochrane, C.G.: Immunologic tissue injury mediated by neutrophilic leukocytes. Advanc. Immunol. 9, 97–162 (1968)
Colman, R.W.: Formation of human plasma kinin. New Engl. J. Med. 291, 509–514 (1974)
Conroy, M.C., Orange, R. P., Lichtenstein, L.M.: Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187. J. Immunol. (1976) (in press)
Coombs, R.R.A., Gell, P.G.H.: Classification of allergic reactions. In: Gell, P.G.H., Coombs, R.R.A. (Eds.): Clinical Aspects of Immunology, 2nd Ed., pp.575–596. Oxford: Blackwell 1968
Csongrady, A., Kobinger, W.: Investigations into the positive inotropic effect of Clonidine in isolated hearts. Naunyn-Schmiedebergs Arch. Pharmacol. 282, 123–128 (1974)
Cuatrecasas, P., Hollenberg, M.D., Chang, K.-J., Bennett, V.: Hormone receptor complexes and their modulation of membrane function. In: Greep, R.O. (Ed.): Recent Progress in Hormone Research, Vol.XXXI, pp. 37–84. New York: Academic Press 1975
Czarnetzki, B.M., König, W., Lichtenstein, L.M.: Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A 23187 and phagocytosis. Nature (Lond.) 258, 725–726 (1975)
Czarnetzki, B.M., König, W., Lichtenstein, L.M.: Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes. Inflammation 1, 201–215 (1976 a)
Czarnetzki, B.M., König, W., Lichtenstein, L.M.: Eosinophil chemotactic factor (ECF). I: Release from polymorphonuclear leukocytes by the calcium ionophore A 23187. J. Immunol. 117, 229–234 (1976 b)
DeBernardo, R.M., Askenase, P., Tauben, D., Douglas, J.: Augmented anaphylaxis at sites of cutaneous basophil hypersensitivity (CBH). J. Allergy clin. Immunol. 55, 112 (abs.) (1975)
Dolovich, J., Hargreave, F.E., Chalmers, R., Shier, K.J., Gauldie, J., Bienenstock, J.: Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy clin. Immunol. 52, 38–46 (1973)
Douglas, W.W.: Stimulus-secretion coupling: The concept and clues from chromaffin and other cells. Brit. J. Pharmacol. 34, 451–474 (1968)
Douglas, W.W.: Histamine and antihistamines: 5-hydroxytryptamine and antagonists. In: Goodman, L.S., Gilman, A. (Eds.): The Pharmacological Basis of Therapeutics, 5th Ed., pp. 590–629. New York: Macmillan 1975
Drakontides, A.B., Gershon, M.D.: 5-hydroxytryptamine receptors in the mouse duodenum. Brit. J. Pharmacol. 33, 480–492 (1968)
Drazen, J.M., Austen, K.F.: Effects of intravenous administration of slow reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2α on pulmonary mechanics in the guinea pig. J. clin. Invest. 53, 1679–1685 (1974)
Drazen, J.M., Austen, K.F.: Atropine modification of the pulmonary effects of chemical mediators in the guinea pig. J. appl. Physiol. 38, 834–838 (1975)
Durant, G.J., Ganellin, C.R., Parsons, M.E.: Chemical differentiation of histamine H1 and H2-receptor agonists. J. Med. Chem. 18, 905–909 (1975)
Dvorak, A.M., Mihm, M.C., Jr., Dvorak, H.F.: Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab. Invest. 34, 179–191 (1976)
Dvorak, H.F., Dvorak, A.M.: Cutaneous basophil hypersensitivity. In: Brent, L., Holborow, J. (Eds.): Progress in Immunology II, Vol.III, pp.171–181. Amsterdam: North-Holland 1974
Eichmann, K.: Idiotype suppression. II Amplification of a suppressor cell with anti-idiotype activity. Europ. J. Immunol. 5, 511–517 (1975)
Eyre, P.: Histamine H2-receptors in the sheep bronchus and cat trachea: the action of burim-amide. Brit. J. Pharmacol. 48, 321–323 (1973)
Fallah, H.A., Maillard, J.L., Voison, G.A.: Regulatory mast cells. I. Suppressive action of their products on an in vitro primary immune reaction. Ann. Immunol. (Inst. Pasteur) 126 C, 669–682 (1975)
Foreman, J.D., Mongar, J.L., Gomperts, B.D.: Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature (Lond.) 245, 249–251 (1973)
Gerschenfeld, H.M., Paupardin-Tritsch, D.: Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine. J. Physiol. (Lond.) 243, 427–456 (1974a)
Gerschenfeld, H.M., Paupardin-Tritsch, D.: On the transmitter function of 5-hydroxytryptamine at excitatory and inhibitory monosynaptic junctions. J. Physiol. (Lond.) 243, 457–481 (1974b)
Gershon, M.D., Ross, L.L.: Studies on the relationship of 5-hydroxytryptamine and enterochro-maffin cell to anaphylactic shock in mice. J. exp. Med. 115, 367–382 (1961)
Gershon, R.K., Askenase, P.W., Gershon, M.D.: Requirement for vasoactive amines for production of delayed-type hypersensitivity skin reactions. J. exp. Med. 142, 732–747 (1975)
Gillespie, E., Lichtenstein, L.M.: Histamine release from human leukocytes: studies with deuterium oxide, colchicine and cytochalasin B. J. clin. Invest. 51, 2941–2947 (1972)
Gleich, G.J., Jacob, G.L.: Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein. Science 190, 1106–1108 (1975)
Glovsky, M.M., Hugli, T.E., Ishizaka, T., Lichtenstein, L.M.: Studies on C3a hu on human leukocyte binding and histamine release. Fed. Proc. 36, 1264 (abs.) (1977)
Godfrey, S.: Exercise-induced asthma—clinical, physiological, and therapeutic implications. J. Allergy clin. Immunol. 56, 1–17 (1975)
Goldberg, N.D., Haddox, M.K., Nicol, S.E., Glass, D.B., Sanford, C.H., Kuehl, F.A., Jr., Estensen, R.: Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis. In: Drummond, G.L., Greengard, P., Robison, G.A. (Eds.): Advances in Cyclic Nucleotide Research, Vol. V, pp. 307–330. New York: Raven Press 1975
Goth, A.: Histamine release by drugs and chemicals. In: Schachter, M. (Ed.): Histamine and Antihistamines, International Encyclopedia of Pharmacology and Therapeutics, Sect. 74, Vol. I, pp.25–43. Oxford: Pergamon Press 1973
Grant, J.A., Dupree, E., Goldman, A.S., Schultz, D.K., Jackson, A.L.: Complement-induced release of histamine in human leukocytes. J. Immunol. 114, 1101–1106 (1975)
Grant, J.A., Lichtenstein, L.M.: Reversed in vitro anaphylaxis induced by anti-IgG: specificity of the reaction and comparison with antigen-induced histamine release. J. Immunol. 109, 20–25 (1972)
Green, J. P., Maayani, S.: Tricyclic antidepressant drugs block histamine H2 receptor in brain. Nature 269, 163–165 (1977)
Green, J.P., Johnson, C.L., Weinstein, H., Maayani, S.: Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Proc. nat. Acad. Sci. (Wash.) 74, 5697–5701 (1977)
Hastie, R.: A study of the ultrastructure of human basophil leukocytes. Lab. Invest. 31, 223–231 (1974)
Henney, C.S., Gaffney, J., Bloom, B.R.: On the relation of soluble mediators to cell-mediated cytolysis. J. exp. Med. 140, 837–852 (1974)
Henson, P.M.: Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen. J. exp. Med. 131, 287–306 (1970)
Henson, P.M.: Pathologic mechanisms in neutrophil mediated injury. Amer. J. Path. 68, 593–605 (1972)
Henson, P.M.: Mechanisms of activation and secretion by platelets and neutrophils. In: Brent, L., Holborow, J. (Eds.): Progress in Immunology II, Vol.II, pp.95–105. Amsterdam: North-Holland 1974
Hill, H.R., Estensen, R.D., Quie, P.G., Hogan, N.A., Goldberg, N.D.: Modulation of human neutrophil chemotactic responses by cyclic 3′5′-guanosine monophosphate and cyclic 3′5′-aden-osine monophosphate. Metabolism 24, 447–456 (1975)
Hook, W.A., Siraganian, R.P., Wahl, S.M.: Complement-induced histamine release from human basophils. I. Generation of activity in human serum. J. Immunol. 114, 1185–1190 (1975)
Hook, W.A., Schiffman, E., Aswanikumar, S., Siraganian, R.P.: Histamine release by chemotactic, formyl methionine-containing peptides. J. Immunol. 117, 594–596 (1976)
Ida, S., Hooks, J.J., Siraganian, R.R., Notkins, A.L.: Enhancement of IgE-mediated histamine release from human basophils by viruses: Role of interferon. J. exp. Med. 145, 892–906 (1977)
Ishizaka, K., Ishizaka, T.: Identification of γ E antibodies as a carrier of reaginic activity. J. Immunol. 99, 1187–1198 (1967)
Ishizaka, K., Ishizaka, T., Kishimoto, T., Okudaira, T.: Biosynthesis of IgE antibodies and mechanisms of sensitization. In: Brent, L., Holborow, J. (Eds.): Progress in Immunology II, Vol. IV, pp.7–17. Amsterdam: North-Holland 1974
Ishizaka, T., DeBernardo, R., Tomioka, H., Lichtenstein, L.M., Ishizaka, K.: Identification of basophil granulocytes as a site of allergic histamine release. J. Immunol. 108, 1000–1008 (1972)
Ishizaka, T., Ishizaka, K.: Biology of immunoglobulin E. In: Kallós, R., Waksman, B.H., de Weck, A. (Eds.): Progress in Allergy, Vol.XIX, pp.60–121. Basel: Karger 1975
Jakschik, R.A., Falkenhein, S., Parker, C.W.: Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc. nat. Acad. Sci. (Wash.) 74, 4577–4581 (1977)
Kahlson, G., Rosengren, E.: New approaches to the physiology of histamine. Physiol. Rev. 48, 155–196 (1968)
Kaliner, M., Orange, R.P., Austen, K.F.: Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. IV. Enhancement by cholinergic and alpha adrenergic stimulation. J. exp. Med. 136, 556–567 (1972)
Kaliner, M., Austen, K.F.: Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J. Immunol. 112, 664–674 (1974)
Kaplan, A.P., Austen, K.F.: Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response. J. Allergy clin. Immunol. 56, 491–506 (1975)
Kaplan, A.P., Gray, L., Shaff, R.E., Horakowa, Z., Beaven, M.A.: In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J. Allergy clin. Immunol. 55, 394–402 (1975)
Katz, S.I., Parker, D., Turk, J.L.: Mechanisms involved in the expression of Jones-Mote hypersensitivity. I. Passive transfer studies. Cell. Immunol. 16, 396–403 (1975)
Kay, A.B., Austen, K.F.: The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J. Immunol. 107, 899–902 (1971)
Kenatin, T.R., Krueger, C.A., Cook, D.A.: Temperature-dependent interconversion of histamine H1 and H2-receptors in guinea pig ileum. Nature (Lond.) 252, 54–55 (1974)
Klein, I., Levey, G.S.: Activation of myocardial adenyl cyclase by histamine in guinea pig, cat and human heart. J. clin. Invest. 50, 1012–1015 (1971)
Kniker, W.T.: Modulation of the inflammatory response in vivo: Prevention or amelioration of immune complex diseases. In: Lepow, I.H., Ward, P.A. (Eds.): Inflammation, Mechanisms and Control, pp. 335–363. New York: Academic Press 1972
Kniker, W.T., Cochrane, C.G.: Pathogenic factors in vascular lesions of experimental serum sickness. J. exp. Med. 122, 83–97 (1965)
König, W., Czarnetzki, B.M., Lichtenstein, L.M.: Eosinophil chemotactic factor (ECF). II: Release during phagocytosis of human polymorphonuclear leukocytes. J. Immunol. 117, 235–241 (1976)
König, W., Ishizaka, K.: Binding of IgE with the subcellular fragments of normal rat mast cells. Immunochemistry 13, 345–353 (1976)
Koopman, W.M., Gillis, M.H., David, J.R.: Prevention of MIF activity by agents known to increase cellular cyclic AMP. J. Immunol. 110, 1609–1614 (1973)
Kravis, T.C., Zvaifler, N.J.: Alteration of rabbit PCA reactions by drugs known to influence intracellular cyclic AMP. J. Immunol. 113, 244–250 (1974)
LaPierre, J.-G., Gold, M., Levison, H., Bryan, A.C., Orange, R.P.: The effects on lung mechanics of infusion of chemical mediators through the bronchial and pulmonary arteries. Fed. Proc. 35, 395 (abs.) (1976)
Lepow, I.H., Willms-Kretschmer, K., Patrick, R.A., Rosen, F.S.: Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Amer. J. Path. 61, 13–24 (1970)
Lett-Brown, M.A., Leonard, E. J.: Histamine-induced inhibition of normal human basophil Chemotaxis to C5a. J. Immunol. 118, 815–818 (1977)
Levi, R., Capurro, N., Lee, C.-H.: Pharmacological chracterization of cardiac histamine receptors: Sensitivity to H1 and H2-receptor agonists and antagonists. Europ. J. Pharmacol. 30, 328–335 (1975)
Levy, D.A.: Histamine and serotonin. In: Weissmann, G. (Ed.): Mediators of Inflammation, pp. 85–111. New York: Plenum Press 1974
Lewis, R.A., Goetzl, E.J., Wasserman, S.I., Valone, F.H., Rubin, R.H., Austen, K.F.: The release of four mediators of immediate hypersensitivity from human leukemic basophils. J. Immunol. 114, 87–92 (1975)
Lewis, R.A., Wasserman, S.I., Goetzl, E.J., Austen, K.F.: Formation of SRS-A in human lung tissue and cells before release. J. exp. Med. 140, 1133–1146 (1974)
Lichtenstein, L.M.: The immediate allergic response: in vitro separation of antigen activation, decay and histamine release. J. Immunol. 107, 1122–1130 (1971)
Lichtenstein, L.M.: Allergy. In: Bach, F., Good, R. (Eds.): Clinical Immunobiology, pp. 243–269. New York: Academic Press 1972
Lichtenstein, L.M.: The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187. J. Immunol. 114, 1692–1699 (1975)
Lichtenstein, L.M., DeBernardo, R.: The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release. J. Immunol. 107, 1131–1136 (1971)
Lichtenstein, L.M., Gillespie, E.: Inhibition of histamine release by histamine is controlled by an H2 receptor. Nature (Lond.) 244, 287–288 (1973)
Lichtenstein, L.M., Gillespie, E.: The effects of the H1 and H2 antihistamines on “allergic” histamine release and its inhibition by histamine. J. Pharmacol, exp. Ther. 192, 441–450 (1975)
Lichtenstein, L.M., Gillespie, E., Bourne, H.: Studies on the biochemical mechanisms of IgE mediated histamine release. In: Ishizaka, K., Dayton, D.H. (Eds.): The Biological Role of the Immunoglobulin E System, pp. 165–186 National Inst. Child Hlth Human Develop. 1972
McDonald, J.R., Mathison, P.A., Stevenson, D.D.: Aspirin intolerance in asthma: detection by oral challenge. J. Allergy clin. Immunol. 50, 198–207 (1972)
Makman, M.H.: Properties of adenyl cyclase of lymphoid cells. Proc. nat. Acad. Sci. (Wash.) 68, 885–889 (1971)
Malveaux, F.J., Conroy, M.C., Adkinson, N.F., Jr., Lichtenstein, L.M.: IgE receptors on human basophils: Relationship to serum IgE concentration. J. clin. Invest. (1978) (in press)
Maslinski, C.: Histamine and its metabolism in mammals. Part I. Chemistry and formation of histamine. Part II. Catabolism of histamine and histamine liberation. Agents Actions 5, 89–107 and 183–225 (1975)
Matthyssens, G.E., Hurwitz, E., Girol, D., Sela, M.: Binding of histamine- and other ligand-conjugated macromolecules to lymphocytes. Molec. cell. Biochem. 7, 119–126 (1975)
Maudsley, D.V., Kobayashi, Y., Williamson, E., Bovaird, L.: H2-receptor blockade and stimulation of histidine decarboxylase. Nature New Biol. 245, 148–149 (1973)
Melmon, K.L., Bourne, H.R., Weinstein, Y., Sela, M.: Receptors for histamine can be detected on the surface of selected leukocytes. Science 177, 707–709 (1972)
Melmon, K.L., Bourne, H.R., Weinstein, Y., Shearer, G. M., Kram, J., Bauminger, S.: Hemolytic plaque formation by leukocytes in vitro. J. clin. Invest. 53, 13–21 (1974)
Mendoza, G., Metzger, H.: Distribution and valency of receptor for IgE on rodent mast cells and related tumor cells. Nature 264, 548–550 (1976)
Moore, T.C.. Histidine decarboxylase inhibitors and the survival of skin homografts. Nature (Lond.) 215, 871–872 (1967)
Moore, T.C., Lawrence, W., Jr.: Suppression of antibody formation by histidine decarboxylase inhibitors. Transplantation 8, 224–234 (1969)
Moore, T.C., Lemmi, C.A.E., Orlando, J.C., Pinkerton, W.: Correlation of splenic histidine decarboxylase activity and antibody formation following SRBC immunization. Transplantation 11, 346–348 (1971)
Moore, T.C., Schayer, R.W.: Histidine decarboxylase activity of autografted and allografted rat skin. Transplantation 7, 99–104 (1969)
Mozes, E., Weinstein, Y., Bourne, H.R., Melmon, K.L., Shearer, G.M.: In vitro correction of antigen-induced immune suppression. Effects of histamine, dibutyryl cyclic AMP and cholera enterotoxin. Cell. Immunol. 11, 57–63 (1974)
Newball, H.H., Talamo, R.C., Lichtenstein, L.M.: Release of leukocyte kallikrein mediated by IgE. Nature (Lond.) 254, 635–636 (1975).
Orange, R.P.: The formation and release of slow reacting substance of anaphylaxis in human lung tissues. In: Brent, L., Holborow, T. (Eds.): Progress in Immunology II, Vol. IV, pp. 29–39. Amsterdam: North-Holland 1974
Orange, R.P.: Dissociation of the immunological release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A and B. J. Immunol. 114, 182–186 (1975)
Orange, R. P., Austen, K.F.: The immunological release of chemical mediators of immediate type hypersensitivity from human lung. In: Amos, B. (Ed.): Progress in Immunology I, pp. 173–186. New York: Academic Press 1971
Orange, R.P., Murphy, R.C., Austen, K.F.: Inactivation of slow-reacting substance of anaphylaxis (SRS-A) by arylsulfatase. J. Immunol. 113, 316–322 (1974)
Orange, R.P., Murphy, R.C., Karnovsky, M.D., Austen, K.F.: The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J. Immunol. 110, 760–770 (1973)
Orange, R.P., Stechschulte, D.J., Austen, K.F.: Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic release of histamine and slow-reacting substance of anaphylaxis (SRS-A). J. Immunol. 105, 1087–1102 (1970).
Orange, R.P., Valentine, M.D., Austen, K.F.: Antigen-induced release of slow reacting substance of anaphylaxis (SRS-Araf) in rats prepared with homologous antibody. J. exp. Med. 127, 767–782 (1968)
Parish, W.E.: Skin sensitizing non-IgE antibodies. Association between IgG S-TS and IgG4. In: Brent, L., Holborow, I., (Eds.): Progress in Immunology II, Vol. IV, pp. 19–27, Amsterdam: North-Holland 1974
Parmley, R.T., Spicer, S.S., Wright, N.J.: The ultrastructural identification of tissue basophils and mast cells in Hodgkin’s disease. Lab. Invest. 32, 469–475 (1975)
Parsons, M.E., Owen, D.A.A., Ganellin C.R., Durant, G.J.: Dimaprit-[S-[3-(N,N-dimethylamino)propyl]isothiourea]—A highly specific histamine H2-receptor agonist. Part 1. Pharmacology. Agents and Actions 7, 31–37 (1977)
Plaut, M.: Unpublished observations (1976)
Plaut, M., Lichtenstein, L.M., Gillespie, E., Henney, C.S.: Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J. Immunol. 111, 389–394 (1973a)
Plaut, M., Lichtenstein, L.M., Henney, C.S.: Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens. Nature (Lond.) 244, 284–287 (1973b)
Plaut, M., Lichtenstein, L.M., Henney, C.S.: Properties of a subpopulation of T cells bearing histamine receptors. J. clin. Invest. 55, 856–874 (1975a)
Plaut, M., Lichtenstein, L.M., Henney, C.S.: Activities mediated by histamine receptor-bearing T lymphocytes. Fed. Proc. 34, 1004 (abs.) (1975b)
Plaut, M.: In vivo and in vitro desensitization of histamine receptor-bearing cytolytically active cells. Fed. Proc. 36, 1324 (abs.) (1977)
Plaut, M.: Unpublished observations (1978)
Plaut, M., Berman, I.J.: Histamine receptors on human and mouse lymphocytes. J. Allergy clin. Immunol. 61, 132–133 (abs.) (1978)
Pounder, R.E., Hunt, R.H., Stekelmann, R., Milton-Thompson, G.J., Misiewicz, J.J.: Healing of gastric ulcer during treatment with cimetidine. Lancet 1967I, 337–339
Powell, J.R., Brody, M.J.: Participation of H1 and H2 histamine receptors in physiological vasodilator responses. Am. J. Physiol. 231, 1002–1009 (1976)
Prausnitz, C., Küstner, H.: Studien über die Überempfindlichkeit. Zbl. Bakt. 86, 160–169 (1921)
Rapp, H.J.: The release of a slow-reacting substance (SRS) in the peritoneal cavity of rats by antigen-antibody interaction. J. Physiol. (Lond.) 158, 35P (1961)
Remold-O’Donnell, E.: Stimulation and desensitization of macrophage adenylate cyclase by prostaglandins and catecholamines. J. biol. Chem. 249, 3615–3621 (1974)
Riley, J. F.: Functional significance of histamine and heparin in tissue mast cells. Ann. N.Y. Acad. Sci. 103, 151–163 (1963)
Rocha E., Silva, M. (sub-ed.).: Histamine: Its chemistry, metabolism and physiological and pharmacological actions. In: Eichler, O., Farah, A. (Eds.): Handbook of Experimental Pharmacology, Vol. XVIII/1, New Berlin-Heidelberg-New York: Springer 1966
Rocklin, R.E.: Modulation of cellular immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J. clin. Invest. 57, 1051–1058 (1976)
Rocklin, R.E.: Histamine-induced suppressor factor (HSF): Effect on migration inhibitory factor (MIF) production and proliferation. J. Immunol. 118, 1734–1738 (1977)
Roszkowski, W., Plaut, M., Lichtenstein, L.M.: Histamine receptor display on lymphocyte sub-populations. Fed. Proc. 36, 1241 (abs.) (1977a)
Roszkowski, W., Plaut, M., Lichtenstein, L.M.: Selective display of histamine receptors on lymphocytes. Science 195, 683–685 (1977)
Saavadra, J.M., Brownstein, M., Axelrod, J.: A specific and sensitive enzymatic isotope microassay for serotonin in tissues. J. Pharmacol. exp. ther. 186, 509–515 (1973)
Samter, M., Czarny, P.: Secondary cells involved in the allergic reaction: eosinophils, basophils, neutrophils. In: Samter, M. (Ed.): Immunologic Diseases, Vol. I, pp. 375–399. 2nd edit. Boston: Little Brown 1971
Schayer, R.A.: Induced synthesis of histamine, microcirculatory regulation and the mechanism of action of the adrenal glucocorticoid hormones. In: Kallos, P., Waksman, B.H. (Eds.): Progress in Allergy. Vol. VII, pp. 187–212. Basel: Karger 1963
Schellenberg, R.R., Adkinson, N.F., Jr.: Measurement of absolute amounts of antigen-specific human IgE by a radioallergosorbent test (RAST) elution technique. J. Immunol. 115, 1577–1583 (1975)
Schellenberg, R.R., Adkinson, N.F., Jr.: Absolute quantitation of serum IgE specific for two independent allergens: correlation with other allergic indices. J. Allergy clin. Immunol. 57, 229 (abs.) (1976)
Schwartz, A., Askenase, P.W., Gershon, R.K.: The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J. Immunol. 118, 159–165 (1977)
Segal, S., Weinstein, Y., Melmon, K.L., McDevitt, H.O.: Termination of tolerance by removal of a suppressor cell. Fed. Proc. 33, 723 (abs.) (1974)
Shearer, G.M., Melmon, K.L., Weinstein, Y., Sela, M.: Regulation of antobody response by cells expressing histamine receptors. J. exp. Med. 136, 1302–1307 (1972)
Shearer, G.M., Weinstein, Y., Melmon, K.L.: Enhancement of immune response potential of mouse lymphoid cells fractionated over insolubilized conjugated histamine columns. J. Immunol. 113, 597–607 (1974)
Shore, P.A., Burkhalter, A., Cohn, V.H., Jr.: A method for the fluorometric assay of histamine in tissues. J. Pharmol. exp. Ther. 127, 182–186 (1959)
Sinclair, M.C., Moore, T.C., Lemmi, C.A.E., Orlando, J.C.: Increase in the urinary excretion of histamine after SRBC immunization of rats. Amer. J. Surg. 126, 624–626 (1973)
Siraganian, R. P.: Refinements in the automated fluorometric histamine analysis system. J. immunol. Methods 7, 283–290 (1975)
Siraganian, R.P., Hook, W.A.: Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction. J. Immunol. 116, 639–646 (1976)
Siraganian, R.P., Osler, A.G.: Destruction of rabbit platelets in the allergic response of sensitized leukocytes. II. Evidence for basophil involvement. J. Immunol. 106, 1252–1259 (1971)
Siraganian, R.P., Siraganian, P.A.: Mechanism of action of concanavalin A on human basophils. J. Immunol. 114, 886–893 (1975)
Slott, R.I., Zweiman, B.: Histologic studies of human skin test responses to ragweed and compound 48/80. II. Effects of corticosteroid therapy. J. Allergy clin. Immunol. 55, 232–240 (1975)
Snyder, S.H., Baldessarini, R.J., Axelrod, J.: A sensitive and specific enzymatic isotopic assay for tissue histamine. J. Pharmol. exp. Ther. 153, 544–549 (1966)
Solley, G.O., Larson, J.B., Jordon, R.E., Gleich, G.J.: Late cutaneous reactions due to IgE. J. Allergy clin. Immunol. 55, 112 (abs.) (1975)
Sosman, J., Busse, W.: Reduced H2 receptor response of granulocytes of asthmatic patients. J. Allergy clin. Immunol. 57, 222 (abs.) (1976)
Spragg, J.: The plasma kinin-forming system. In: Weissmann, G. (Ed.): Mediators of Inflammation, pp. 85–111. New York: Plenum Press 1974
Stechschulte, D.J.: Slow-reacting substances. In: Weissmann, G. (Ed.): Mediators of Inflammation, pp. 181–197. New York: Plenum Press 1974
Stechschulte, D.J., Orange, R. P., Austen, K.F.: Immunologic and biologic properties of rat IgE. I. Immunochemical identification of rat IgE. J. Immunol. 105, 1082–1086 (1970)
Steinberg, P., Ishizaka, K., Norman, P.S.: Possible role of IgE-mediated reaction in immunity. J. Allergy clin. Immunol. 54, 359–366 (1974)
Stoner, J., Manganiello, V.C., Vaughan, M.: Effects of bradykinin and indomethacin on cyclic GMP and cyclic AMP in lung slices. Proc. nat. Acad. Sci. (Wash.) 70, 3830–3833 (1973)
Strannegärd, I.-L., Strannegärd, Ö.: Increased sensitivity of lymphocytes from atopic individuals to histamine-induced suppression. Scand. J. Immunol. 6, 1225–1231 (1977)
Sullivan, T.J., Parker, K.L., Eisen, S.A., Parker, C.W.: Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J. Immunol. 114, 1480–1485 (1975)
Thomas, L.L., Lichtenstein, L.M.: Augmentation of IgE-mediated histamine release from human basophils by phagocytic stimuli. J. Allergy clin. Immunol. 61, 152 (abs.) (1978)
Thomas, L.L., Bochner, B.S., Lichtenstein, L.M.: Inhibition of human PMN-derived histaminase activity by H-2 antagonists. Biochemical Pharmacol. (1978) (in press)
Thompson, J.S., Severson, C.D., Parmely, M.J., Marmorstein, B.L., Simmons, A.: Pulmonary “hypersensitivity” reactions induced by transfusion of non-HL-A leukoagglutinins. New. Engl. J. Med. 284, 1120–1125 (1971)
Thueson, D.O., Speck, L., Grant, J.A.: Histamine releasing activity produced by human mononuclear cells. Fed. Proc. 36, 1300 (abs.) (1977)
Vallota, E.H., Müller-Eberhard, H.J.: Formation of C3a und C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J. exp. Med. 137, 1109–1123 (1973)
Verhaegen, H., DeCock, W., DeCree, J.: Histamine receptor-bearing peripheral T lymphocytes in patients with allergies. J. Allergy clin. Immunol. 59, 266–268 (1977)
Ward, P.A., Dvorak, H.F., Cohen, S., Yoshida, T., Data, R., Selvaggio, S. S.: Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms. J. Immunol. 114, 1523–1531 (1975)
Wasserman, S.L., Austen, K.F.: Arylsulfatase of human lung. Isolation, charaterization, and interaction with slow-reacting substance of anaphylaxis. J. clin. Invest. 57, 738–744 (1976)
Weinstein, Y., Melmon, K.L., Bourne, H.R., Sela, M.: Specific leukocyte receptors for small endogenous hormones. Detection by cell binding to insolubilized hormone preparations. J. clin. Invest. 52, 1349–1361 (1973)
Yellin, T.O., Sperow, J.W., Buck, S.H.: Antagonism of tolazoline by histamine H2-receptor blockers. Nature (Lond.) 253, 561–563 (1975)
Zeiger, R.S., Yurdin, D.L., Colten, H.R.: Histamine catabolism: Localization of histaminase and histamine methyl transferase in human leukocytes. J. Allergy clin. Immunol. 57, 244–245 (abs.) (1976)
Zurier, R.B.: Prostaglandins. In: Weissmann, G. (Ed.): Mediators of Inflammation, pp. 163–180. New York: Plenum Press 1974
Zurier, R.B., Weissmann, G., Hoffstein, S., Cameron, S., Tai, H.H.: Mechanisms of lysozomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J. clin. Invest. 53, 297–309 (1974)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Plaut, M., Lichtenstein, L.M. (1978). Histamine, 5-Hydroxytryptamine, SRS-A: Discussion of Type I Hypersensitivity (Anaphylaxis). In: Vane, J.R., Ferreira, S.H. (eds) Inflammation. Handbook of Experimental Pharmacology, vol 50 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66888-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-66888-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66890-6
Online ISBN: 978-3-642-66888-3
eBook Packages: Springer Book Archive